ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Craig C. Parker has joined the company as Senior Vice President, Strategy and Corporate Development. He will report directly to H. Thomas Watkins, President and Chief Executive Officer, and will serve as a member of the Management Committee of the Company. Mr. Parker was most recently CEO and co-founder of Vega Therapeutics, Inc., a biotechnology start-up focused on inflammation, obesity and insulin resistance. He was formerly Senior Vice President of Corporate Development and Finance and Chief Financial Officer of Proteolix Inc., a venture-backed development stage biotechnology company that was acquired by Onyx Pharmaceuticals in 2009. Prior to Proteolix, he was President of DCD BioConsulting LLC, a strategic and financial advisory firm to the biotechnology industry.
